Bladder cancer test maker Pacific Edge has recorded a $18.98 million loss for the year ending March 31 2020, up from $17.9m the previous year, despite reporting continuing growth and achievement of commercial milestones.
Because the company is loss-making, its auditors have flagged the company
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
